{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:49:18Z","timestamp":1792144158205,"version":"4.4.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T00:00:00Z","timestamp":1475452800000},"content-version":"vor","delay-in-days":1899,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.5"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9,1]]},"DOI":"10.1093\/brain\/awr170","type":"journal-article","created":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T20:13:03Z","timestamp":1311711183000},"page":"2677-2686","source":"Crossref","is-referenced-by-count":471,"title":["A randomized placebo-controlled trial of idebenone in Leber\u2019s hereditary optic neuropathy"],"prefix":"10.1093","volume":"134","author":[{"given":"Thomas","family":"Klopstock","sequence":"first","affiliation":[{"name":"1 Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Yu-Wai-Man","sequence":"additional","affiliation":[{"name":"2 Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne Foundation Hospital, NE1 4LP, NHS Trust, UK"},{"name":"3 Department of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne Foundation Hospital, NE1 4LP NHS Trust, UK"},{"name":"4 Mitochondrial Research Group, Institute of Genetic Medicine, Newcastle University, Central Parkway, Newcastle upon Tyne, NE1 3BZ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Dimitriadis","sequence":"additional","affiliation":[{"name":"1 Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinthe","family":"Rouleau","sequence":"additional","affiliation":[{"name":"5 Ophthalmology Department, Centre Hospitalier de l'Universit\u00e9 de Montr\u00e9al (CHUM), Montreal, Quebec H2L 4M1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzette","family":"Heck","sequence":"additional","affiliation":[{"name":"1 Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Bailie","sequence":"additional","affiliation":[{"name":"2 Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne Foundation Hospital, NE1 4LP, NHS Trust, UK"},{"name":"3 Department of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne Foundation Hospital, NE1 4LP NHS Trust, UK"},{"name":"4 Mitochondrial Research Group, Institute of Genetic Medicine, Newcastle University, Central Parkway, Newcastle upon Tyne, NE1 3BZ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Atawan","sequence":"additional","affiliation":[{"name":"2 Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne Foundation Hospital, NE1 4LP, NHS Trust, UK"},{"name":"3 Department of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne Foundation Hospital, NE1 4LP NHS Trust, UK"},{"name":"4 Mitochondrial Research Group, Institute of Genetic Medicine, Newcastle University, Central Parkway, Newcastle upon Tyne, NE1 3BZ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip","family":"Chattopadhyay","sequence":"additional","affiliation":[{"name":"2 Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne Foundation Hospital, NE1 4LP, NHS Trust, UK"},{"name":"3 Department of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne Foundation Hospital, NE1 4LP NHS Trust, UK"},{"name":"4 Mitochondrial Research Group, Institute of Genetic Medicine, Newcastle University, Central Parkway, Newcastle upon Tyne, NE1 3BZ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Schubert","sequence":"additional","affiliation":[{"name":"1 Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aylin","family":"Garip","sequence":"additional","affiliation":[{"name":"6 Department of Ophthalmology, Ludwig-Maximilians-University, Munich, 80336 Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Kernt","sequence":"additional","affiliation":[{"name":"6 Department of Ophthalmology, Ludwig-Maximilians-University, Munich, 80336 Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Petraki","sequence":"additional","affiliation":[{"name":"7 Santhera Pharmaceuticals, 4410 Liestal, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Rummey","sequence":"additional","affiliation":[{"name":"7 Santhera Pharmaceuticals, 4410 Liestal, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Leinonen","sequence":"additional","affiliation":[{"name":"8 4Pharma, Stockholm, 16440 Kista, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnther","family":"Metz","sequence":"additional","affiliation":[{"name":"7 Santhera Pharmaceuticals, 4410 Liestal, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip G.","family":"Griffiths","sequence":"additional","affiliation":[{"name":"2 Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne Foundation Hospital, NE1 4LP, NHS Trust, UK"},{"name":"3 Department of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne Foundation Hospital, NE1 4LP NHS Trust, UK"},{"name":"4 Mitochondrial Research Group, Institute of Genetic Medicine, Newcastle University, Central Parkway, Newcastle upon Tyne, NE1 3BZ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Meier","sequence":"additional","affiliation":[{"name":"7 Santhera Pharmaceuticals, 4410 Liestal, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick F.","family":"Chinnery","sequence":"additional","affiliation":[{"name":"2 Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne Foundation Hospital, NE1 4LP, NHS Trust, UK"},{"name":"3 Department of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne Foundation Hospital, NE1 4LP NHS Trust, UK"},{"name":"4 Mitochondrial Research Group, Institute of Genetic Medicine, Newcastle University, Central Parkway, Newcastle upon Tyne, NE1 3BZ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,7,23]]},"reference":[{"key":"key\n\t\t\t\t20180611050740_B1","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1136\/bjo.2003.033480","article-title":"Colour vision testing as an aid to diagnosis and management of age related maculopathy","volume":"88","author":"Arden","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"key\n\t\t\t\t20180611050740_B2","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1001\/archneur.62.5.730","article-title":"Severe impairment of complex I-driven adenosine triphosphate synthesis in leber hereditary optic neuropathy cybrids","volume":"62","author":"Baracca","year":"2005","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20180611050740_B3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ophtha.2004.06.034","article-title":"Retinal nerve fiber layer evaluation by optical coherence tomography in Leber's hereditary optic neuropathy","volume":"112","author":"Barboni","year":"2005","journal-title":"Ophthalmology"},{"key":"key\n\t\t\t\t20180611050740_B4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4321\/S0365-66912007000600012","article-title":"Response to idebenone and multivitamin therapy in Leber's hereditary optic neuropathy","volume":"82","author":"Barnils","year":"2007","journal-title":"Arch Soc Esp Oftalmol"},{"key":"key\n\t\t\t\t20180611050740_B5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0022-510X(98)00239-1","article-title":"Leber's Hereditary Optic Neuropathy (LHON) with 14484\/ND6 mutation in a North African patient","volume":"160","author":"Carelli","year":"1998","journal-title":"J Neurol Sci"},{"key":"key\n\t\t\t\t20180611050740_B6","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/jnnp.71.6.813","article-title":"Leber's hereditary optic neuropathy (LHON\/11778) with myoclonus: report of two cases","volume":"71","author":"Carelli","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20180611050740_B7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-510X(96)00311-5","article-title":"Clinical and brain bioenergetics imporvement with idebenone in a patient with Leber's hereditary optic neuropathy: a clinical and 31P-MRS study","volume":"148","author":"Cortelli","year":"1997","journal-title":"J Neurol Sci"},{"key":"key\n\t\t\t\t20180611050740_B8","first-page":"3252","article-title":"Correlation of chromatic, spatial, and temporal sensitivity in optic nerve disease","volume":"32","author":"Grigsby","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key\n\t\t\t\t20180611050740_B9","first-page":"125","article-title":"Clinical global impression","volume-title":"Assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"key":"key\n\t\t\t\t20180611050740_B10","doi-asserted-by":"crossref","first-page":"e17963","DOI":"10.1371\/journal.pone.0017963","article-title":"NQO1-Dependent redox cycling of idebenone: effects on cellular redox potential and energy levels","volume":"6","author":"Haefeli","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180611050740_B11","first-page":"77","article-title":"Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation","volume":"57","author":"Harding","year":"1995","journal-title":"Am J Hum Genet"},{"key":"key\n\t\t\t\t20180611050740_B12","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1167\/iovs.08-3166","article-title":"Quality of life in patients with leber hereditary optic neuropathy","volume":"50","author":"Kirkman","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key\n\t\t\t\t20180611050740_B13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00417-008-0926-0","article-title":"Resolving the clinical acuity categories \"hand motion\" and \"counting fingers\" using the Freiburg Visual Acuity Test (FrACT)","volume":"247","author":"Lange","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key\n\t\t\t\t20180611050740_B14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/346066","article-title":"The epidemiology of leber hereditary optic neuropathy in the north East of England","volume":"72","author":"Man","year":"2003","journal-title":"Am J Hum Genet"},{"key":"key\n\t\t\t\t20180611050740_B15","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/0140-6736(92)91442-B","article-title":"Remission of Leber's hereditary optic neuropathy with idebenone","volume":"340","author":"Mashima","year":"1992","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180611050740_B16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00041327-200020030-00006","article-title":"Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy?","volume":"20","author":"Mashima","year":"2000","journal-title":"J Neuroophthalmol"},{"key":"key\n\t\t\t\t20180611050740_B17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ajo.2005.03.058","article-title":"Prophylaxis for second eye involvement in leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine purite","volume":"140","author":"Newman","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"key\n\t\t\t\t20180611050740_B18","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0002-9394(14)76784-4","article-title":"The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy with the 11 778 mutation","volume":"111","author":"Newman","year":"1991","journal-title":"American Journal of Ophthalmology"},{"key":"key\n\t\t\t\t20180611050740_B19","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0161-6420(96)30665-9","article-title":"Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations","volume":"103","author":"Nikoskelainen","year":"1996","journal-title":"Ophthalmology"},{"key":"key\n\t\t\t\t20180611050740_B20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/brain\/118.2.319","article-title":"The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation","volume":"118","author":"Riordan-Eva","year":"1995","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180611050740_B21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbabio.2004.09.005","article-title":"The epidemiology of mitochondrial disorders-past, present and future","volume":"1659","author":"Schaefer","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t20180611050740_B22","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/ICU.0b013e3283313d4e","article-title":"Optical coherence tomography: another useful tool in a neuro-ophthalmologist's armamentarium","volume":"20","author":"Subei","year":"2009","journal-title":"Curr Opin Ophthalmol"},{"key":"key\n\t\t\t\t20180611050740_B23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/eye.1997.87","article-title":"Visual acuity scored by the letter-by-letter or probit methods has lower retest variability than the line assignment method","volume":"11","author":"van den Bosch","year":"1997","journal-title":"Eye"},{"key":"key\n\t\t\t\t20180611050740_B24","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1167\/iovs.06-0331","article-title":"Male prevalence of acquired color vision defects in asymptomatic carriers of Leber's hereditary optic neuropathy","volume":"48","author":"Ventura","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key\n\t\t\t\t20180611050740_B25","volume-title":"Linear Mixed Models for Longitudinal Data","author":"Verbeke","year":"2000"},{"key":"key\n\t\t\t\t20180611050740_B26","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s10495-005-0742-5","article-title":"Caspase-independent death of Leber's hereditary optic neuropathy cybrids is driven by energetic failure and mediated by AIF and Endonuclease G","volume":"10","author":"Zanna","year":"2005","journal-title":"Apoptosis"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/134\/9\/2677\/25031551\/awr170.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T08:31:05Z","timestamp":1560414665000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/134\/9\/2677\/411764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,23]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2011,7,23]]},"published-print":{"date-parts":[[2011,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awr170","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.13200051.14542223","asserted-by":"object"}]},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,9]]},"published":{"date-parts":[[2011,7,23]]}}}